Search Results for " Atripla "
Atripla Related Products
Atripla is a fixed-dose combination medication used to treat HIV (Human Immunodeficiency Virus) infection. It combines three different antiretroviral drugs into one tablet, making it easier for individuals with HIV to manage their treatment regimen.
SynZeal is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Atripla, pharmacopeial and non-pharmacopeial Atripla impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Atripla impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.
Atripla-related products are thoroughly characterized. Atripla products are supplied with detailed COA & analytical data meeting regulatory compliance. We can also provide EP/USP traceable standards based on your requirements. The supplied products are re-tested at regular intervals.